Livzon Pharmaceutical Group ( (HK:1513) ) just unveiled an update.
Livzon Pharmaceutical Group Inc. announced the appointment of Mr. Xu Xiao as the vice president responsible for production operations. Mr. Xu, with extensive experience within the company and a strong educational background in pharmaceutics and engineering, is expected to enhance the company’s operational capabilities. This appointment reflects Livzon’s strategic focus on strengthening its leadership team to improve production efficiency and maintain its competitive position in the pharmaceutical industry.
More about Livzon Pharmaceutical Group
Livzon Pharmaceutical Group Inc. is a company operating in the pharmaceutical industry, focusing on the production and research of pharmaceutical products. The company is involved in various aspects of pharmaceutical manufacturing and research, with a market focus on developing and producing medical drugs.
YTD Price Performance: -0.29%
Technical Sentiment Signal: Buy
Current Market Cap: $3.93B
See more insights into 1513 stock on TipRanks’ Stock Analysis page.